Patents by Inventor Matthew Hitron

Matthew Hitron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER
    Publication number: 20200397740
    Abstract: The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.
    Type: Application
    Filed: April 7, 2020
    Publication date: December 24, 2020
    Applicant: Sumitomo Dainnipon Pharma Oncology. Inc.
    Inventors: Chiang Jia Li, Wei Li, David Leggett, Youzhi Li, David Kerstein, Matthew Hitron
  • Methods for treating cancer
    Patent number: 10646464
    Abstract: Methods for treating advanced thymoma and thymic carcinoma in a subject comprising administering and kits comprising at least one paclitaxel compound and at least one compound of formula (I) (2-acetylnaphtho[2,3-b]furan-4,9-dione) as disclosed herein.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: May 12, 2020
    Assignee: Boston Biomedical, Inc.
    Inventors: Chiang Jia Li, Youzhi Li, Wei Li, Matthew Hitron, Yuan Gao
  • 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
    Patent number: 10543189
    Abstract: The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: January 28, 2020
    Assignee: Boston Biomedical, Inc.
    Inventors: Chiang Jia Li, Wei Li, David Leggett, Youzhi Li, David Kerstein, Matthew Hitron
  • 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER
    Publication number: 20190388382
    Abstract: The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.
    Type: Application
    Filed: August 16, 2019
    Publication date: December 26, 2019
    Inventors: Chiang Jia Li, Wei Li, David Leggett, Youzhi Li, David Kerstein, Matthew Hitron
  • METHODS FOR TREATING CANCER
    Publication number: 20180333385
    Abstract: Methods for treating advanced thymoma and thymic carcinoma in a subject comprising administering and kits comprising at least one paclitaxel compound and at least one compound of formula (I) (2-acetylnaphtho[2,3-b]furan-4,9-dione) as disclosed herein.
    Type: Application
    Filed: May 16, 2018
    Publication date: November 22, 2018
    Inventors: Chiang Jia Li, Youzhi Li, Wei Li, Matthew Hitron, Yuan Gao